Although there are changes in gene expression and alterations in neuronal density and afferent inputs in the forebrain of trisomic mouse models of Down syndrome (DS) and Alzheimer's disease (AD), there is a lack of systematic assessments of gene expression and encoded proteins within individual vulnerable cell populations, precluding translational investigations at the molecular and cellular level. Further, no effective treatment exists to combat intellectual disability and basal forebrain cholinergic neurodegeneration seen in DS. To further our understanding of gene expression changes before and following cholinergic degeneration in a well-established mouse model of DS/ AD, the Ts65Dn mouse, we assessed RNA expression levels from CA1 pyramidal neurons at two adult ages (6 months of age and 11 months of age) in both Ts65Dn and their normal disomic 
neurological and peripheral phenotype associated with DS (Sturgeon & Gardiner, 2011) . Further complicating the DS phenotype, by the midthird decade of life, DS individuals develop pathological changes associated with Alzheimer's disease (AD), including amyloid-beta peptide (Ab) containing senile plaques, neurofibrillary tangles (NFTs), degeneration of cholinergic basal forebrain (CBF) neurons, and early endosomal abnormalities (Cataldo et al., 2000; Hartley et al., 2015; Hartley et al., 2014; Lai & Williams, 1989; Leverenz & Raskind, 1998; Mann, Yates, Marcyniuk, & Ravindra, 1986; Sendera et al., 2000; Wisniewski et al., 1985) . In addition, degeneration of the CBF neuron projection system, which provides the major cholinergic innervation to the entire cortical mantle and the hippocampus (Mesulam, Mufson, Levey, & Wainer, 1983; Mufson, Counts, Perez, & Ginsberg, 2008; Rye, Wainer, Mesulam, Mufson, & Saper, 1984) , found in DS, is similar to that observed in AD (Bierer et al., 1995; Leverenz & Raskind, 1998; Mann et al., 1986; Wisniewski et al., 1985) .
Mouse models have been generated that recapitulate aspects of DS and AD for translational study. The well-established segmental trisomy Ts65Dn mouse model closely replicates human DS neuropathology (Cataldo et al., 2003; Davisson et al., 1993; Granholm, Sanders, & Crnic, 2000; Holtzman et al., 1996; Salehi et al., 2006; Seo & Isacson, 2005) . This model translocates a segment of mouse chromosome 16 (MMU16) and mouse chromosome 17 (MMU17) orthologous to HSA21 to <10% of the centromere of MMU17, creating a freely segregating chromosome (Akeson et al., 2001; Kahlem et al., 2004; Reeves et al., 1995) with a conservation of 70% homology for >85 protein coding gene sequences, with over 250 genes and putative gene products triplicated (Davisson et al., 1993; Gardiner, Fortna, Bechtel, & Davisson, 2003; Sturgeon & Gardiner, 2011) . Ts65Dn mice mimic many key features of the human DS pathology, including hippocampaldependent learning and memory deficits (Ash et al., 2014; Escorihuela et al., 1995; Hyde & Crnic, 2001; Reeves et al., 1995; Velazquez et al., 2013) , attentional deficits (Moon et al., 2010; Powers et al., 2016 Powers et al., , 2017 , heightened emotionality (Driscoll et al., 2004; Moon et al., 2010) , and hyperactivity (Cooper et al., 2001; Hunter, Bimonte, & Granholm, 2003; Reeves et al., 1995) . Glutamatergic neurotransmission dysfunction, including impaired hippocampal long-term potentiation and enhanced long-term depression, has been observed in trisomic mice (Kaur et al., 2014; Kleschevnikov et al., 2004; Rueda et al., 2010; Siarey et al., 1999) . Like their human DS counterparts, Ts65Dn mice have intact basal forebrain cholinergic neurons (BFCNs) and septohippocampal organization at birth (Granholm et al., 2000; Holtzman et al., 1996; Hunter et al., 2003) , but after 6 months of age (MO), Ts65Dn mice have significant BFCN and associated CA1 hippocampal degeneration, along with astrocytic hypertrophy, and microglial activation (Cooper et al., 2001; Granholm et al., 2000; Holtzman et al., 1996; Kelley et al., 2014b; Seo & Isacson, 2005) . The septohippocampal circuit is vulnerable in both DS and AD, and Ts65Dn mice recapitulate aspects of this vulnerability through reduced hippocampal neurogenesis, synapse loss, and deficits in neuroplasticity (Belichenko et al., , 2009 Granholm et al., 2003; Insausti et al., 1998; Kelley et al., 2014a Kelley et al., , 2016 Kleschevnikov et al., 2012; Kurt, Davies, Kidd, Dierssen, & Florez, 2000) .
Current therapeutics for DS and AD are largely ineffective and expensive, and none prevent the progression of the disease. A potential treatment modality originating from the study of mouse models of DS and AD is to supplement the maternal diet with additional choline during pregnancy and lactation . Choline is an essential nutrient critical for several key developmental pathways in the brain, including the biosynthesis of acetylcholine, which regulates neuronal proliferation, differentiation, migration, plasticity and synapse formation . In addition, choline is a key substrate of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway, which generates phosphatidylcholine species, crucial elements in neuronal and non-neuronal lipid membranes (Lindblom & Oradd, 2009; Wang, Megill, Wong, Kirkwood, & Lee, 2016; Zeisel, 2010; Zeisel & Niculescu, 2006) .
Choline is also the primary dietary source of methyl groups, a principal driver of gene expression regulation through epigenetic programming (McGowan, Meaney, & Szyf, 2008; Mehedint, Niculescu, Craciunescu, & Zeisel, 2010) . Current dietary recommendations for choline, especially in regard to pregnant women, are likely to be inadequate for the high demand for choline during gestation (Caudill, Strupp, Muscalu, Nevins, & Canfield, 2017; Institute of Medicine NAoSU, 1998; Strupp et al., 2016) .
Notably, maternal choline supplementation (MCS) has been demonstrated by our group to improve spatial cognition and attentional function, protect BFCNs, and normalize adult hippocampal neurogenesis in Ts65Dn offspring (Ash et al., 2014; Kelley et al., 2014a Kelley et al., , 2016 Powers et al., 2016 Powers et al., , 2017 Strupp et al., 2016; Velazquez et al., 2013) . MCS treatment also increases choline acetyltransferase (ChAT) intensity in the hippocampus prior to BFCN degeneration in the Ts65Dn mouse model . Further investigation of aging and MCS treatment shows an increase in ChAT intensity in 2N animals, but not in Ts65Dn mice when examined pre-BFCN degeneration (4-6 MO) and post-BFCN degeneration (14-18 MO), however this may be explained by the fact that unsupplemented Ts65Dn mice display septohippocampal degeneration during the aging process . MCS has also been shown to protect the cholinergic system in a mouse model of amyloid-beta precursor protein (APP) overexpression (Mellott et al., 2017) and behavioral and morphologic benefits in several models of neurodevelopmental disorders (Bearer, Wellmann, Tang, He, & Mooney, 2015; Ross et al., 2016; Scremin, Roch, Norman, Djazayeri, & Liu, 2015; Stevens et al., 2008; Ward, Agarwal, Wang, Berger-Sweeney, & Kolodny, 2008; Kolodny, Nag, & Berger-Sweeney, 2009 ), indicating that the effects are broadly neuroprotective across several disease entities.
To understand mechanisms and signaling pathways underlying benefits of MCS at the molecular and cellular level within vulnerable neuronal populations in DS and AD, we examined gene expression changes in CA1 pyramidal neurons at two distinct timepoints, young (6 MO; pre-BFCN degeneration) and middle-aged (11 MO; post-BFCN degeneration) by single population expression profiling analysis. We postulate that cognitive improvement via MCS is reflected in select gene expression and septohippocampal signaling pathway changes in trisomic mice. Breeder pairs (female Ts65Dn and male C57Bl/6J Eicher x C3H/HeSnJ F1 mice) were purchased from Jackson Laboratories (Bar Harbor, ME) and mated at Nathan Kline Institute, Orangeburg, NY. Upon arrival, breeder pairs were assigned to receive one of two choline-controlled experimental diets: (a) control rodent diet containing 1.1 g/kg choline chloride (AIN-76A; Dyets Inc., Bethlehem, PA), or (b) cholinesupplemented diet containing 5.0 g/kg choline chloride (AIN-76A; Dyets Inc.), as described previously (Kelley et al., 2014a; Powers et al., 2016 Powers et al., , 2017 . The choline-supplemented diet provides approximately 4.5 times the concentration of choline consumed by our control group, and is within the normal physiological range (Detopoulou, Panagiotakos, Antonopoulou, Pitsavos, & Stefanadis, 2008). The control diet supplies an adequate level of choline, so the offspring are not choline deficient. Breeder pairs were provided ad libitum access to water and their assigned diets. Standard cages contained paper bedding and several objects for enrichment (e.g., plastic igloo, t-tube, and cotton square). Mice were maintained on a 12-hr light-dark cycle under temperature-and humidity-controlled conditions.
| Tissue preparation
Pups born to choline supplemented (Ts65Dn1 and 2N1) or unsupplemented maternal choline (Ts65Dn and 2N) dams were weaned on postnatal day 21 and provided ad libitum access to water and the control diet. Tail clips were taken and genotyped as described by Duchon 2N1 n 5 11 (6 MO), n 5 8 (11 MO); 2N n 5 12 (6 MO), n 5 7 (11 MO);
Ts65Dn1 n 5 16 (6 MO), n 5 8 (11 MO); and Ts65Dn n 5 19 (6 MO), n 5 6 (11 MO). The study used both male and female mice. Mice were given an overdose of ketamine and xylazine and perfused transcardially with ice-cold 4% paraformaldehyde buffered in 0.15 M phosphate buffer. Tissue blocks containing the dorsal hippocampus were paraffin embedded and 6 lm-thick tissue sections were cut in the coronal plane on a rotary microtome for immunocytochemistry as described previously (Alldred, Duff, & Ginsberg, 2012; Ginsberg, 2005a Ginsberg, , 2010 (n 5 9) per timepoint were accrued for RNA extraction.
| Single cell microaspiration and TC RNA amplification
Laser capture microdissection (LCM) and terminal continuation (TC)
RNA amplification procedures have been described in detail previously by our group (Alldred, Duff, & Ginsberg, 2008 , 2009 Alldred et al., 2012; Che & Ginsberg, 2004; Ginsberg, 2008) . Individual CA1 pyramidal neurons were microaspirated via LCM (Arcturus PixCell IIe, ThermoFisher, South San Francisco, CA). One hundred cells were captured per reaction for population cell analysis (Alldred et al., 2008; Ginsberg, 2010) . Microarrays (containing 100 LCM-captured CA1 neurons each) were performed per mouse brain (2-5 times per mouse).
The full TC RNA amplification protocol is available at http://cdr.rfmh.
org/pages/ginsberglabpage.html. This method entails synthesizing first strand cDNA complementary to the RNA template, re-annealing the primers to the cDNA, and finally in vitro transcription using the synthesized cDNA as a template. Briefly, microaspirated CA1 neurons were homogenized in Trizol reagent (ThermoFisher, Carlsbad, CA), chloroform extracted, and precipitated (Alldred et al., 2009 (Alldred et al., , 2012 Alldred, Lee, Petkova, & Ginsberg, 2015a , 2015b . RNAs were reverse transcribed and single-stranded cDNAs were then subjected to RNase H digestion and re-annealing of the primers to generate cDNAs with double-stranded regions at the primer interfaces. Single stranded cDNAs were digested and samples were purified by Vivaspin 500 columns (Sartorius Stedim Biotech, Goettingen, Germany). Hybridization probes were synthesized by in vitro transcription using 33 P and radiolabeled TC RNA probes were hybridized to custom-designed cDNA arrays without further purification.
| Microarray platforms and hybridization
Array platforms consist of 1 lg of linearized cDNA purified from plasmid preparations adhered to high-density nitrocellulose (Hybond XL, GE Healthcare, Piscataway, NJ) using an arrayer robot (VersArray, Bio-Rad, Hercules, CA) (Ginsberg, 2005b (Ginsberg, , 2008 . Each cDNA and/or expressed sequence-tagged cDNA (EST) was verified by sequence analysis and restriction digestion. Mouse and human clones were employed on the custom-designed array. Approximately 576 cDNAs/ESTs were utilized for the younger cohort and approximately 649 genes were utilized for the older cohort, organized into 22 gene ontology (GO) groups (Table 1 ). The older cohort of animals had additional genes newly available and/or implicated in DS/AD pathology. Additional genes were mainly added to three GO categories, protein phosphatases and kinases, stress response, and sirtuins (Table 1) . The majority of genes are represented by one transcript on the array platform, although the neurotrophin receptors TrkA, TrkB, and TrkC are represented by ESTs that contain the extracellular domain as well as the tyrosine kinase domain (TK) (Ginsberg et al., 2006 .
Statistical procedures for custom-designed microarray analysis have been described in detail previously (Alldred et al., 2015a (Alldred et al., , 2015b Schafer, Dolgalev, Alldred, Heguy, & Ginsberg, 2015) .
Gene expression differences due to genotype or dietary condition
were assessed with respect to the hybridization signal intensity ratio of the total signal of all array genes. For each gene the signal intensity ratio was modeled as a function of mouse study group, using mixed effects models with random mouse effect to account for the correlation between repeated assays on the same mouse (McCulloch, Searle, & Neuhaus, 2011) . Significance was judged at the level a 5 0.01, twosided; false discovery rate based on an empirical null distribution due to strong correlation between genes (Benjamini & Hochberg, 1995; Efron, 2007) was controlled at level a 5 0.1. Expression levels were graphed using a bioinformatics software package (SPSS Statistics 22, IBM, Barbados). 
2.5 | qPCR qPCR was performed on microdissected CA1 sections from an independent cohort of animals containing the hippocampal CA1 region from 6 MO and 11 MO Ts65Dn and 2N mice. Taqman qPCR primers (ThermoFisher, Waltham, MA) were utilized for qPCR (Table 2) .
Samples were assayed on a real-time qPCR cycler (PikoReal, ThermoFisher) in 96-well optical plates with coverfilm as described previously (Alldred et al., 2008 (Alldred et al., , 2012 (Alldred et al., , 2015a (Alldred et al., , 2015b Jiang et al., 2010) . Standard curves and cycle threshold (Ct) were generated using standards obtained from total mouse brain RNA. The ddCT method was employed to determine relative gene level differences between study groups (ABI, 2004; Alldred et al., 2008; Ginsberg, 2010; Jiang et al., 2010 were compared with respect to the PCR product synthesis for each gene tested. PCR product synthesis was modeled as a function of mouse study group, using mixed effects models with random mouse effect to account for the correlation between repeated assays on the same mouse (Alldred et al., 2015a (Alldred et al., , 2015b McCulloch et al., 2011) . Significance was judged at the level a 5 0.05, two-sided.
| RE S U L TS
To determine beneficial gene expression changes associated with perinatal MCS treatment, we examined CA1 pyramidal neurons at two distinct timepoints, young mice at 6 MO (prior to BFCN degeneration) and middle-aged mice at 11 MO (following BFCN degeneration), postulating that in addition to known cognitive benefits , MCS would delay septohippocampal degeneration seen in Ts65Dn offspring (Ash et al., 2014) , and approximate the gene expres- Figure 6a ) and gamma-aminobutyric acid (GABA) type A receptor beta-1 subunit (Gabrb1, Figure 6b ).
| Assessment of select gene expression by qPCR
qPCR was performed on an independent cohort of 6 MO trisomic and 2N mice using RNA extracted from CA1 hippocampal microdissec-
tions. Results indicated that Synj1 is significantly downregulated in
Ts65Dn mice by dietary intervention (e.g., Ts65Dn1 vs. Ts65Dn), although there was no genotype difference (e.g., Ts65Dn vs. 2N; Figure 7 ). Mapk13, Camk2a, and p75 NTR did not show any significant differences in the admixed microdissected tissue (Figure 7 ).
Using an independent 11 MO cohort, qPCR revealed that Apbb1, App, and Casp8 showed partial or full normalization of genotyperelated changes by MCS. However, expression differences for Apbb1
and Casp8 the in the admixed tissues assayed by qPCR were in the opposite direction of the microarray results (Figure 8a ), illustrating one of the caveats of comparing single-population expression profiles with admixed cell population transcript analyses. In contrast, Bace1 did not a show significant change in Ts65Dn mice nor attenuation due to MCS (Figure 8a ). Genes involved in stress response and cell homeostasis also showed either partial or fully normalized gene expression to 2N levels in Ts65Dn1 mice, including Dyrk1a, Hsf1, Mapk13, and Prkaa2, consistent with microarray results (Figure 8b ). In contrast, Sesn2 did not show significant differences by maternal diet or genotype (Figure 8b ).
| D ISC USSION
We report significant expression level changes in young and middle- Gabrb1 is downregulated 1.43 fold (2N vs. Ts) in Ts65Dn mice and upregulated in Ts1 mice (Ts1 vs. Ts) to 2N levels by MCS. Key: **p < .005; ***, p < .001. Upward arrowhead, significant upregulation; downward arrowhead, significant downregulation 
| Synaptic plasticity and AD-like neurodegeneration
Synj1 is triplicated in both the Ts65Dn mouse and human DS (Martin et al., 2014) . We found that Synj1 expression levels are normalized by MCS. Upregulation of Synj1 has been linked to increases in Ab and endosomal abnormalities in DS (Cossec et al., 2012; Martin et al., 2014; Zhu et al., 2013) . Notably, genetic reduction of Synj1 leads to synaptic and behavioral rescue in an AD mouse model (McIntire et al., 2012) . In contrast, Synpo is decreased in postmortem CA1 pyramidal neurons during the progression of dementia from mild cognitive impairment to AD, and this downregulation correlates with cognitive decline (Counts, Alldred, Che, Ginsberg, & Mufson, 2014) . Loss of Synpo has also been reported to coincide with loss of dendritic spines and spine apparatus, with concomitant deficits in learning and memory and synaptic plasticity (Deller et al., 2007) . Therefore, a balance of Synpo expression is likely needed for proper synaptic activity and plasticity. Co-expression of p75 NTR and App has been shown to result in apoptosis, and decrease of this pan-neurotrophin receptor has been linked to both prevention of the cognitive decline and reduction of amyloid burden in AD mice (Fombonne, Rabizadeh, Banwait, Mehlen, & Bredesen, 2009; Yao et al., 2015) . Further, p75 NTR when bound to the precursor of NGF (proNGF) or the precursor to BDNF (proBDNF), can induce apoptosis (Mufson et al., 2012; Pedraza et al., 2005; Teng et al., 2005) indicating that upregulation of this receptor is potentially detrimental to neuronal health and survival. Ece2 has been identified as a regulator of Ab clearance (Eckman et al., 2003; Pacheco-Quinto & Eckman, 2013) .
However, upregulation of Ece2 is found in postmortem AD patients with vascular pathology, indicating a need for balanced expression (Miners, van Helmond, Kehoe, & Love, 2010; Miners et al., 2014) . Likewise, Ide is a thiol metallo-endopeptidase that acts as a protease regulating cerebral Ab levels (Qiu et al., 1998; Wang et al., 2010) . However, Ide-driven breakdown of Ab competes with insulin as a substrate (Haque & Nazir, 2014) , and the higher insulin levels seen in DS (Anwar, Walker, & Frier, 1998; Bergholdt, Eising, Nerup, & Pociot, 2006) previously shown by our group (Ash et al., 2014; Kelley et al., 2014a Kelley et al., ,2016 Powers et al., 2016 Powers et al., , 2017 Strupp et al., 2016; Velazquez et al., 2013) .
| Cellular homeostasis regulation
We hypothesize that MCS is neuroprotective to the offspring, especially as they age. Specifically, MCS treatment partially restores cellular homeostasis, resulting in Ts65Dn mice that do not aberrantly express genes involved in cellular energy regulation, effectively attenuating aberrant phenotypic effects on DS/AD response genes, aging and oxidative function and excitation and inhibition of neuronal transmitters.
For example, we observed normalized expression of two catalytic subunits in the 5 0 adenosine monophosphate-activated protein kinase (AMPK) complex signaling cascade that interact with each other, Prkaa2 and Prkag1 (Wong & Lodish, 2006) . Consistent with this observation, Prkab2, the beta catalytic subunit of the AMPK complex, was upregulated in the postmortem human AD CA1 region by microarray assessment (Blalock, Buechel, Popovic, Geddes, & Landfield, 2011) .
Related genes attenuated by MCS associated with the AMPK or downstream pathways include Hsf1, Dyrk3, and Sesn2. Hsf1 has been previously shown to be involved in protein homeostasis (Su & Dai, 2016) , and is activated by synaptic depolarization (Hooper et al., 2016) . Further, Hsf1 nuclear translocation and activation upregulates multiple synaptic genes including Bdnf and Psd95 (Hooper et al., 2016; Wang et al., 2017) . Dyrk3 regulates stability of the mammalian target of rapamycin complex 1 (mTORC1) pathway during cellular stress, which is a downstream target of AMPK (Wippich et al., 2013) . Dyrk3 has also been shown to be involved with dendritic branching (Slepak, Salay, Lemmon, & Bixby, 2012) , and in conjunction with Dyrk1a, promotes cell survival through phosphorylation of sirtuin 1 (Sirt1) (Guo, Williams, Schug, & Li, 2010) , indicating dysregulation may negatively impact multiple signaling pathways, including the AMPK cascade. Sesn2 is a critical factor mediating reactive oxygen species formation, in part by inhibiting AMPK pathway member mTORC1 (Ebnoether, Ramseier, Cortada, Bodmer, & Levano-Huaman, 2017) . Sesn2 is also induced by Ab exposure in vitro and upregulated in serum of AD patients (Chen, Chen, Wu, Huang, & Yang, 2014; Rai et al., 2016) . Therefore, normalization of the AMPK cascade and/or downstream signaling pathway members, as seen with MCS, may be considered therapeutic targets in DS and AD.
| AD-related genes
We demonstrate several key genes implicated in AD and DS pathobiology are MCS-responsive in Ts65Dn mice. For example, Adam10 is upregulated in Ts65Dn mice and attenuated by MCS. Studies have shown increased Adam10 levels in AD hippocampus, and two rare Adam10 mutations attenuate a-secretase activity (Gatta, Albertini, Ravid, & Finazzi, 2002; Kim et al., 2009) . Adam10 is present and active in synaptic vesicles, including those enriched in APP C-terminal fragments (CTFs), and colocalizes with Bace1 and synaptophysin, which may result in APP processing within synaptic vesicles (Lundgren et al., 2015) . Dyrk1a is upregulated in DS and AD (Ferrer et al., 2005; Kimura et al., 2007; Lockstone et al., 2007) , may dysregulate the 3-repeat tau to 4-repeat tau ratio (Wegiel, Gong, & Hwang, 2011) , and is part of the (Jiang et al., , 2016 . Alternatively, Bace1 deficiency may be considered detrimental, as a loss of Bace1 expression impairs myelination (Hu, Hu, Dai, Trapp, & Yan, 2015) and causes hippocampal synaptic deficits (Petrus & Lee, 2014; Wang et al., 2014; Zhu et al., 2016) , illustrating the need for normative Bace1 levels. MCS also restores the normal expression of two truncated forms of tau (Mapt2N6D and Mapt2N6P). Little is known about the normal expression of these truncated forms of tau, especially in relation to the DS phenotype, but this may reflect a compensatory change by MCS to permit optimized tau processing, including truncation of the N-and C-terminal domains. Further, the App binding protein Fe65 (Apbb1) is upregulated to 2N levels by MCS in trisomic mice, which may be neuroprotective. Moreover, in addition to its role in processing APP (Chow, Cheung, Li, & Lau, 2015) , Apbb1 is a key protein in the cellular response to genotoxic stress (Ryu et al., 2015) . Taken together, these varied expression level changes reveal the need for greater understanding of Ab processing and tau metabolism within vulnerable neurons in DS and AD models.
Limitations of the study include a caveat that expression-profiling studies, even those that employ single-population analysis, do not infer causality, but provide highly relevant targets for the study of mechanistic interactions for in vitro and in vivo experiments as well as identify potential targets for clinical trials. We recognize that the Ts65Dn mouse model does not recapitulate the full pathobiology of AD or DS, and is one of many models that could have been chosen for these studies. Discrepancies between human AD, DS transcriptomic profiles, and the trisomic model could be envisioned, as the Ts65Dn mouse has >90 triplicated genes that are not located on HSA21 (Sturgeon & Gardiner, 2011) . Despite lacking total genetic overlap with DS and not displaying NFTs or Ab deposition like AD, Ts65Dn mice are one of the few models available that mimics both behavioral and cognitive decline of AD and DS, including age-related cognitive deficits such as spatial learning, working memory, reference memory, and attention (Ash et al., 2014; Escorihuela et al., 1995; Hyde & Crnic, 2001; Reeves et al., 1995; Velazquez et al., 2013) . Future studies may include studying the use of MCS in aged Ts65Dn mice as well as employing Dp16 DS models, APP overexpressing models, and tauopathy models in conjunction with the MCS paradigm. Additional studies comparing the expression profile of trisomic septohippocampal neurons with septohippocampal neurons following cholinotoxic delivery, such as either by ethylcholine mustard aziridinium ion (AF64A) (Fan & Hanin, 1999) or 192 IgG-saporin (Wiley, Oeltmann & Lappi, 1991) may also be considered. 
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